A Study of Barrett's Esophagus Patients to Investigate Quality of Life and Fear of Cancer, and Optimize a Risk Model Based on Biomarkers and New Technologies to Better Predict the Development of Cancer
מצבים רפואיים
Barrett's Esophagus · Esophageal Adenocarcinoma
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
University Hospital Antwerp, Edegem, Antwerpen, Belgium
Contact: Principal Investigator (Prof. Dr. Sheila Krishnadath)Sint-Augustinus Hospital (ZAS), Wilrijk, Antwerpen, Belgium
Contact: Principal Investigator (Dr. Thomas Botelberge)UZ Gent, Ghent, Belgium
Contact: Principal Investigator (Dr. David Tate)AZ Delta, Roeselare, Belgium
Contact: Principal Investigator (Dr. Dominiek De Wulf)Rigshospitalet, Copenhagen, Denmark
Contact: Study coordinator (Prof. Dr. Michael Patrick Achiam) · michael.patrick.achiam.01@regionh.dk · +45 35 45 04 41Contact: Principal Investigator (Prof. Dr. Michael Patrick Achiam)CHU LILLE - Centre Hospitalier Universitaire de Lille, Lille, France
Contact: Principal Investigator (Prof. Dr. Guillaume Piessen)St James's Hospital, Dublin, Ireland
Contact: Principal Investigator (Prof. Jacintha O Sullivan)IRCCS Ospedale San Raffaele, Milan, Milano, Italy
Contact: Principal Investigator (Dr. Silvio Danese)Karolinska University Hospital, Solna, Sweden
Contact: Study coordinator (Dr. Henrik Maltzman)Contact: Principal Investigator (Dr. Fredrik Klevebro)
מובילי המחקר
Sheila Krishnadath
Principal Investigator
Universitair Ziekenhuis Antwerpen (UZA)